Pga

Founded in 2012, PGA+ was established to offer Pharmacovigilance services in Brazil, just three years after the national regulation of the field. Since then, we have evolved alongside the regulatory landscape and the strengthening of the patient safety culture in Brazil and Latin America, consolidating our presence in over 35 countries. Our portfolio is expanding to meet the needs of the market and our partners. In addition to the pharmaceutical and medical device sectors, we have extended our expertise to nutrition and cosmetics, with projects in pharmacovigilance, technovigilance, nutrivigilance, and cosmetovigilance. Our goal is to be your strategic partner at every stage of the regulatory journey, with trust and efficiency. Behind PGA+ is a passionate and experienced team, attentive to the unique needs of each client. We work together to deliver customized solutions. With a focus on innovation and a commitment to health and well-being, we operate with transparency, responsibility, respect, and excellence. We are strategic partners for companies that identify with these values. Presence in over 35 countries cases processed regulatory submissions 🧪 molecules monitored in literature We are PGA+ — Excellence in care for a safe future.